Check out our free and informative ezines and sign up now
FDA Commissioner Andrew von Eschenbach told attendees at an April 12 industry conference that the agency needs to face “a new reality” and become a better bridge between new treatments and patients.
This article is viewable by subscribers only. To view this article, please select an option below.
ePublishing :: CMS, Hosting & Web Development | © Copyright